01345nas a2200205 4500000000100000008004100001260003800042653002400080653002900104653001500133653001500148653002500163653001200188653001800200245010700218856008200325300001000407520069300417022002901110 2001 d bWorld Health OrganizationaGeneva10aUrogenital problems10aMass drug administration10aManagement10aLymphedema10aLymphatic filariasis10aGrading10aElephantiasis00aLymphoedema staff mannual: treatment and prevention of problems associated with lymphatic filariasis. uhttp://apps.who.int/iris/bitstream/10665/67224/1/WHO_CDS_CPE_CEE_2001.26a.pdf a87 p.3 a
This training module on the treatment and prevention of lymphoedema due to lymphatic filariasis (LF) consists of two separate parts: Part 1 (this part), the Learner’s Guide, contains all the technical information needed by health workers involved in disability alleviation and prevention. Part 2, the Tutor’s Guide, outlines the main learning points and provides guidance on the learning process for those responsible for conducting training programmes. This document is part of a series on several topics related to lymphatic filariasis that will be produced by the World Health Organization to assist national elimination programmes on the different aspects of the disease.
aWHO/CDS/CPE/CEE/2001.26a